Ferrochelatase is a therapeutic target for ocular neovascularization

MLA

Halesha D Basavarajappa, et al. “Ferrochelatase Is a Therapeutic Target for Ocular Neovascularization.” EMBO Molecular Medicine, vol. 9, no. 6, Apr. 2017, pp. 786–801. EBSCOhost, https://doi.org/10.15252/emmm.201606561.

APA

Halesha D Basavarajappa, Rania S Sulaiman, Xiaoping Qi, Trupti Shetty, Sardar Sheik Pran Babu, Kamakshi L Sishtla, Bit Lee, Judith Quigley, Sameerah Alkhairy, Christian M Briggs, Kamna Gupta, Buyun Tang, Mehdi Shadmand, Maria B Grant, Michael E Boulton, Seung‐Yong Seo, & Timothy W Corson. (2017). Ferrochelatase is a therapeutic target for ocular neovascularization. EMBO Molecular Medicine, 9(6), 786–801. https://doi.org/10.15252/emmm.201606561

Chicago

Halesha D Basavarajappa, Rania S Sulaiman, Xiaoping Qi, Trupti Shetty, Sardar Sheik Pran Babu, Kamakshi L Sishtla, Bit Lee, et al. 2017. “Ferrochelatase Is a Therapeutic Target for Ocular Neovascularization.” EMBO Molecular Medicine 9 (6): 786–801. doi:10.15252/emmm.201606561.